News 22 Jun 2023 Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering admin
News 20 Jun 2023 Daxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meeting admin
News 15 Jun 2023 Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services admin
News 12 Jun 2023 Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference admin
News 25 May 2023 Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering admin
News 22 May 2023 Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering admin
Uncategorized 18 May 2023 New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes admin
News 20 Apr 2023 New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure admin
News 17 Apr 2023 Daxor Corporation to Exhibit at the MedAxiom Cardiovascular Transforum Conference Spring’23 to Advance Awareness and Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100®) admin
